NASDAQ: GNOM       Global X Genomics & Biotechnology ETF
Last Price Today's Change   Day's Range   Trading Volume
19.01   +0.201 (1.07%)  18.89 - 19.013  12,615


Avg Volume (4 weeks):27,205
4 Weeks Range:17.705 - 19.98
4 Weeks Price Volatility (%):
52 Weeks Range:10.16 - 19.98
52 Weeks Price Volatility (%):
Average Price Target: 3.00
Price Target Upside/Downside: -16.01


No recent Headlines for this stock.

Business Background

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2097  3711  435  3145 

Top 10 Active Counters
 LK 1.38+1.38 
 AMD 79.89-2.34 
 ISIG 1.275+0.329 
 OAS 0.155-0.014 
 NIO 27.235+1.225 
 AAPL 116.628+1.578 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 SNAP 41.28+0.01 
 GE 7.175-0.205